News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,171 Results
Type
Article (40875)
Company Profile (267)
Press Release (680019)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204653)
Career Advice (2022)
Deals (35532)
Drug Delivery (110)
Drug Development (81372)
Employer Resources (173)
FDA (16403)
Job Trends (14941)
News (346351)
Policy (32723)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49575)
ALS (168)
Alzheimer's disease (1660)
Antibody-drug conjugate (ADC) (305)
Approvals (16668)
Artificial intelligence (503)
Autoimmune disease (148)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4754)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (731)
Cervical cancer (36)
Clinical research (69496)
Collaboration (1670)
Company closure (4)
Compensation (1147)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (816)
Cystic fibrosis (143)
Data (6160)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (497)
Diagnostics (6670)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90041)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117189)
Executive appointments (959)
FDA (19486)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (586)
GLP-1 (962)
Government (4652)
Grass and pollen (6)
Guidances (383)
Healthcare (18868)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (104)
Infectious disease (2966)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (641)
Lymphoma (372)
Machine learning (42)
Management (59)
Manufacturing (777)
MASH (161)
Medical device (13755)
Medtech (13807)
Mergers & acquisitions (19953)
Metabolic disorders (1254)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (309)
Neuropsychiatric disorders (86)
Neuroscience (2873)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4509)
Now hiring (65)
Obesity (588)
Opinion (257)
Ovarian cancer (164)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (488)
Patient recruitment (473)
Peanut (55)
People (58814)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21666)
Phase 2 (30587)
Phase 3 (22791)
Pipeline (5114)
Policy (278)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (818)
Real estate (5954)
Recruiting (69)
Regulatory (24425)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (185)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (86)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (91)
Last 7 days (564)
Last 30 days (2029)
Last 365 days (29812)
2026 (2901)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39192)
Australia (6405)
California (11166)
Canada (3255)
China (1087)
Colorado (472)
Connecticut (470)
Delaware (332)
Europe (84430)
Florida (1662)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (852)
India (62)
Indiana (515)
Iowa (22)
Japan (420)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1370)
Massachusetts (8001)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2969)
New Mexico (28)
New York (2944)
North Carolina (1436)
North Dakota (8)
Northern California (5442)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2257)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4346)
Tennessee (172)
Texas (1724)
United States (39590)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,171 Results for "castellum inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Castellum, Inc. Announces 2023 Financial Results
Castellum, Inc. announces its results for the year ended December 31, 2023.
March 21, 2024
·
6 min read
Business
Castellum, Inc. Announces New Strategic Alliance
Castellum, Inc. announces a new strategic alliance between its subsidiary Specialty Systems, Inc. (“SSI”) (www.specialtysystems.com ) and Epic Systems, Inc. (“Epic”) (www.epicinfotech.com ).
April 18, 2024
·
4 min read
Business
Castellum, Inc. Announces Third Quarter 2023 Financial Results
Castellum, Inc. announces highlights of its operating results for its third quarter ended September 30, 2023.
November 14, 2023
·
6 min read
BioCapital
Castellum, Inc. Announces 2024 Budget Targets and Strategic Initiatives
Castellum, Inc. announces its 2024 budget targets and some corporate strategic initiatives.
October 20, 2023
·
5 min read
Press Releases
Castellum, Inc. Issues Letter to Shareholders
July 17, 2024
·
7 min read
BioCapital
Castellum Announces Closing of $2.7 Million Registered Direct Offering
Castellum, Inc. announced the closing of its previously announced registered direct offering, consisting of the sale of 8,437,501 shares of common stock.
January 29, 2024
·
4 min read
Deals
Castellum, Inc. Announces Initiation of “Buy” Rating by EF Hutton
Castellum, Inc. announces that EF Hutton has initiated research coverage of Castellum with a “Buy” rating.
April 26, 2023
·
2 min read
Business
Castellum, Inc. Announces Record Annual Results
Castellum, Inc. announces record unaudited results for the year ended December 31, 2022.
March 1, 2023
·
5 min read
BioCapital
Castellum, Inc. Announces $6 million Cost Reduction Plan
Castellum, Inc. announces that it is undertaking a cost reduction effort targeting at least $6 million per year in cash and non-cash indirect costs, general and administrative costs, and overhead costs.
May 26, 2023
·
3 min read
BioCapital
Castellum, Inc. Formally Joins Russell Microcap Index; Comments on Recent Stock Trading Volume
Castellum, Inc. is pleased to announce that it has officially joined the Russell Microcap Index, effective as of the end of trading on June 23, 2023.
June 26, 2023
·
4 min read
1 of 72,118
Next
